Access campaign
Pharmaceutical corporation ViiV must improve its failing access strategy for lifesaving HIV prevention drug
March 31, 2023 | Switzerland
Access campaignPress release
MSF applauds Indian Patent Office’s rejection of Johnson & Johnson’s attempt to extend monopoly on...
March 23, 2023 |
Access campaign
Pharmaceutical corporation ViiV must make ground-breaking HIV prevention injection affordable and available
November 30, 2022 | Switzerland
Access campaignPress release
United Kingdom
MSF responds to UK’s disastrous proposal on intellectual property in UK-India Free Trade Agreement
November 2, 2022 | IndiaUnited Kingdom
Access campaignPress release
Global TB Report 2022: MSF calls for scale up of shorter and safer DR-TB treatments...
October 28, 2022 |
Access campaign
MSF is disappointed with the inadequate outcome after nearly two years of discussions at the...
June 17, 2022 | Switzerland
Access campaign
MSF to governments negotiating at WTO: get it right and adopt the real TRIPS Waiver
June 7, 2022 | Switzerland
Access campaignPress release
COVID-19: MSF urges governments to reject the draft COVID-19 text at WTO that would set...
April 4, 2022 |
Access campaignPress release
Tuberculosis: MSF responds to updated WHO guidelines for tuberculosis in children
March 21, 2022 |
Access campaignPress release
MSF responds to latest WHO recommendation for a COVID-19 therapeutic, baricitinib
January 14, 2022 |
Access campaignPress release
Breakthrough in treatment of HIV-related cryptococcal meningitis gives Gilead another opportunity to fulfil its promise...
July 21, 2021 |
Access campaign
EU, UK, Switzerland, Norway must stop blocking negotiations on landmark pandemic monopoly waiver
June 7, 2021 |
